Advancing Precision Oncology: The Role of Molecular and Genetic Markers in Liquid Biopsy for Urogenital Cancers
Liquid biopsy has emerged as one of the most promising approaches in precision oncology by enabling minimally invasive, real-time molecular characterization of tumors. Despite growing evidence, its clinical utility in urogenital cancers remains insufficiently defined. Differences in tumor biology, assay sensitivity and...